Jasper Therapeutics, Inc.

Amplitude Healthcare Acquisition Corporation, trading on Nasdaq under the ticker AMHC, was a blank-check company that completed its initial public offering in 2019 with a focus on the healthcare and biopharmaceutical sector. The SPAC was sponsored by Amplitude Healthcare Sponsor, LLC, and sought a business combination target within life sciences and healthcare services. AMHC ultimately completed its de-SPAC merger with Jasper Therapeutics, Inc., a clinical-stage biopharmaceutical company developing antibody-based conditioning regimens to enable safer hematopoietic stem cell transplantation for patients with blood disorders and autoimmune diseases. Following the combination, the company continued operations under the Jasper Therapeutics name. Visit SpacDesk and sign up for full data, deal timelines, and sponsor analytics on AMHC and hundreds of other SPAC transactions.